Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.
14 reports, 6 independent
Updated Oct 14
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 14
- Developments
- 6
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Merck and Moderna funded an Australian-led clinical trial involving the University of Sydney.Sub-event
Moderna completed a successful Phase III mRNA vaccine trial with MSD and Geneva University Hospitals.1 source
- Moderna and Merck announced initial results from a late-stage trial for their novel cancer treatment.Sub-event
Merck faces FDA decision deadlines for its cancer vaccine partnership with Moderna.1 source
Collaboration between Moderna and Merck KGaA reaches PDUFA decision deadlines.1 source
Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.1 source